Ubiquigent Limited (“Ubiquigent”), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announce

Targeted protein degradation has opened up a new field of drug discovery with potential to treat previously ‘undruggable’ diseases

A innovative molecular “cut and sew” process by University of Dundee scientists has allowed the design of a research tool that will accelerate drug design for diseases for which no other options ex

LRRK2 Investigative Therapeutics Exchange (LITE) will support new approaches targeting LRRK2, the most common cause of inherited Parkinson’s disease

A young artist who suffered years of life-limiting pain before receiving diagnosis for a rare medical condition has shared how that journey inspired her to make a film, which premiers in Dundee thi

Primary care teams in Dundee have been helping patients who live with respiratory diseases switch to more environmentally sustainability inhalers, saving the equivalent of 590,000 smartphone charge

Ninewells Community Garden is benefiting from a project which aims to improve the economic, social and environmental wellbeing of people living in Tayside.

The University of Dundee has been named Innovative & Entrepreneurial University of the Year in the Triple E Awards for Europe.